United States · FDA National Drug Code directory
Naproxen Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-1061_2d9a3970-0a3a-481f-928d-953ab83d4b9b
- Product NDC
- 71335-1061
- Form
- TABLET, FILM COATED
- Composition / generic term
- Naproxen Sodium
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140411
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN SODIUM — 220 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 20 TABLET, FILM COATED in 1 BOTTLE (71335-1061-1) · 71335-1061-1
- 30 TABLET, FILM COATED in 1 BOTTLE (71335-1061-2) · 71335-1061-2
- 40 TABLET, FILM COATED in 1 BOTTLE (71335-1061-3) · 71335-1061-3
- 50 TABLET, FILM COATED in 1 BOTTLE (71335-1061-4) · 71335-1061-4
- 60 TABLET, FILM COATED in 1 BOTTLE (71335-1061-5) · 71335-1061-5
- 14 TABLET, FILM COATED in 1 BOTTLE (71335-1061-6) · 71335-1061-6
- 100 TABLET, FILM COATED in 1 BOTTLE (71335-1061-7) · 71335-1061-7
- 90 TABLET, FILM COATED in 1 BOTTLE (71335-1061-8) · 71335-1061-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →